Our patients have the opportunity to participate in research studies focused on genetic susceptibility to cancer, cancer risk, screening and prevention. We also have a research laboratory which is dedicated to genetic studies.
Current research studies include:
- Genetic Evaluation of Men (GEM) Registry – A registry of men with and at risk for prostate cancer. We collect medical, family history, behavioral data as well as DNA for cancer risk research.
- myRisk sub-study of the GEM Registry – Offers a clinically available 25-cancer gene test to men with and at risk for prostate cancer. Eligible participants will have the cost of genetic testing covered by the study.
- PROMPT study (multi-institutional study) – Focused on characterizing and interpreting genetic variants in moderate penetrant genes and variants of uncertain significance.
- Cancer Genetics Risk Registry – A registry of patients with any cancer or at-risk individuals evaluated for genetic risk. We will collect medical, family history, behavioral data as well as DNA for cancer risk research.
Please contact Laura Gross at 215-503-5285 for more information about any of these studies.